Physician
Progressive Childrens Clinic LLC
Progressive Childrens Clinic LLC was paid $6.07M by Medicaid between Jan 2018 and Dec 2024, across 70 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 17% of everything it billed.
33Billing provider infoPROGRESSIVE CHILDRENS CLINIC LLC
SHREVEPORT, LA 71101
SHREVEPORT, LA 71101
33aNPI1942573589assigned 02/13/2012
33bProvider typePediatrics Physician
28Total paid$6.07M
24GClaims172,978
24DCodes billed70
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Louisiana
Rank by total paid#21 of 230
Median peer was paid$429K
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 29,088 | $919K | |
| 2019 | 25,737 | $968K | |
| 2020 | 21,991 | $780K | |
| 2021 | 23,541 | $1.08M | |
| 2022 | 25,093 | $972K | |
| 2023 | 24,252 | $733K | |
| 2024incomplete | 23,276 | $613K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 17,314 | 15,315 | $1.02M |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 16% | 3,100 | 2,712 | $963K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 22,427 | 19,955 | $866K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 14% | 2,857 | 2,133 | $865K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.6% | 6,144 | 5,730 | $402K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.1% | 5,706 | 5,377 | $371K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.7% | 5,961 | 5,254 | $348K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3.3% | 15,164 | 14,033 | $203K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.1% | 8,773 | 7,854 | $188K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.7% | 2,260 | 2,118 | $162K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 2.2% | 8,200 | 7,662 | $135K |
| 87632 | 1.4% | 657 | 448 | $83K |
58 more codes
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.3% | 856 | $78K |
| 92551 | 1.2% | 9,285 | $71K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,790 | $45K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 439 | $36K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 3,753 | $27K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,468 | $27K |
| 90474 | <1% | 2,223 | $18K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 700 | $17K |
| 87581 | <1% | 652 | $16K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 649 | $16K |
| 87486 | <1% | 652 | $16K | |
| 99173 | <1% | 9,240 | $15K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 4,424 | $14K |
| 99381 | <1% | 145 | $10K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,434 | $7K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 216 | $6K |
| 0072A | <1% | 157 | $6K | |
| 0071A | <1% | 168 | $6K | |
| 96161 | <1% | 655 | $4K | |
| 99383 | <1% | 41 | $3K | |
| 96127 | <1% | 1,837 | $3K | |
| 0002A | <1% | 78 | $3K | |
| 0001A | <1% | 75 | $3K | |
| 90677 | <1% | 707 | $2K | |
| 99382 | <1% | 24 | $2K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 69 | $1K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 13 | $1K |
| 81002 | <1% | 581 | $1K | |
| 90647 | <1% | 2,852 | $1K | |
| 87807 | <1% | 199 | $1K | |
| 99384 | <1% | 16 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 28 | $769.95 |
| 96380 | <1% | 47 | $673.17 | |
| 99499 | <1% | 58 | $646.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 62 | $580.08 |
| 90656 | <1% | 570 | $454.62 | |
| 90651 | <1% | 621 | $436.17 | |
| 90620 | <1% | 40 | $165.00 | |
| 90670 | <1% | 3,603 | $65.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 21 | $28.50 |
| 90680 | <1% | 2,746 | $25.00 | |
| 90723 | <1% | 2,741 | $25.00 | |
| 90686 | <1% | 5,234 | $12.50 | |
| 94760 | <1% | 18 | $6.57 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 81 | $2.57 |
| 90633 | <1% | 1,494 | $1.70 | |
| 90381 | <1% | 44 | $0.07 | |
| 90707 | 0% | 1,310 | $0.00 | |
| 90700 | 0% | 354 | $0.00 | |
| 90734 | 0% | 429 | $0.00 | |
| 90715 | 0% | 102 | $0.00 | |
| 99072 | 0% | 200 | $0.00 | |
| 90713 | 0% | 12 | $0.00 | |
| 91300 | 0% | 208 | $0.00 | |
| 90716 | 0% | 1,305 | $0.00 | |
| 91307 | 0% | 386 | $0.00 | |
| 90696 | 0% | 213 | $0.00 | |
| 99000 | 0% | 90 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKAMPERT, AMANDA (OWNER)